MYOTONIA
Clinical trials for MYOTONIA explained in plain language.
Never miss a new study
Get alerted when new MYOTONIA trials appear
Sign up with your email to follow new studies for MYOTONIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Experimental drug aims to control debilitating muscle disease
Disease control OngoingThis global Phase 3 trial is testing whether an intravenous drug called AOC 1001 can help control symptoms of myotonic dystrophy type 1, a genetic muscle-wasting disease. About 159 adults with a confirmed diagnosis will receive either the drug or a placebo via infusion every 8 we…
Matched conditions: MYOTONIA
Phase: PHASE3 • Sponsor: Avidity Biosciences, Inc. • Aim: Disease control
Last updated Mar 30, 2026 14:33 UTC
-
Four-Year trial tests potential new treatment for debilitating muscle disease
Disease control ENROLLING_BY_INVITATIONThis study is testing the long-term safety and effectiveness of an investigational drug called del-desiran for adults with myotonic dystrophy type 1 (DM1), a genetic muscle-wasting disease. Participants who completed a previous related study will receive an intravenous infusion o…
Matched conditions: MYOTONIA
Phase: PHASE3 • Sponsor: Avidity Biosciences, Inc. • Aim: Disease control
Last updated Mar 30, 2026 14:28 UTC
-
Shocking space suit aims to keep Astronauts' muscles strong
Knowledge-focused ENROLLING_BY_INVITATIONThis study is testing a special full-body suit that uses mild electrical stimulation on astronauts living on the International Space Station. The goal is to see if adding this stimulation to their regular exercise routine helps keep their muscles healthier and stronger during lon…
Matched conditions: MYOTONIA
Phase: NA • Sponsor: Charite University, Berlin, Germany • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:29 UTC